Standards; Pharmaceutical/API Drug Impurities/Metabolites;
應(yīng)用:
5-?[[[(2,?4-?Difluorophenyl)?methyl]?amino]?carbonyl]?-?1-?(2,?2-?dimethoxyethyl)?-?1,?4-?dihydro-?3-?methoxy-?4-?oxo-2-pyridinecarboxylic Acid Methyl Ester is an intermediate in the synthesis of Cabotegravir-d3 (C050102), which is the labelled form of Cabotegravir (C050100). Cabotegravir is a long acting HIV-1 integrase inhibitor with action against a broad range of HIV subtypes.